
| 2014 | |
|---|---|
| Criterium: | Position: |
| Overall Score: | > 1000 |
| Networking Rank (Reputation): | > 1000 |
Total number of projects: 2
As coordinator: 1
As participant: 1
Sole participant: 0
Coordinator / Participant Ratio: 1*
| Total project funding [€]: | Projects [No]: | |||||
|---|---|---|---|---|---|---|
| Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
| 2021 | 9.195.134 | 0 | 6.834.696 | 1 | ||
| 2014 | 0 | 1.992.770 | 956.450 | 1 | ||
Total number of partners: 11
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 11
Frequent / Rare Partner Ratio: 0
| Start date | Project | acronym | role | funding | partners |
|---|---|---|---|---|---|
| 2021-06-01 | Equine Polyclonal antibodies Immunotherapy against COVID-19/SARS-CoV2–VOC | EPIC-CROWN-2 | coordinator | 9.195.134 | 5 |
| 2014-11-01 | Control of the Ebola Oubreak by both innovative Ultrasensitive Detection of EBOV and therapy | IF-EBOla | participant | 1.992.770 | 8 |